PIMJS
PKO Investment Management Joint-Stock Portfolio holdings
AUM
$931M
This Quarter Return
-19.17%
1 Year Return
+16.38%
3 Year Return
+65%
5 Year Return
+112.48%
10 Year Return
+522.82%
AUM
$695M
AUM Growth
+$695M
(-16%)
Cap. Flow
+$51M
Cap. Flow
% of AUM
7.34%
Top 10 Holdings %
Top 10 Hldgs %
48.93%
Holding
129
New
12
Increased
39
Reduced
39
Closed
3
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
$19M |
| 2 |
Amazon
AMZN
|
$12.1M |
| 3 |
NVIDIA
NVDA
|
$7.73M |
| 4 |
EOG Resources
EOG
|
$3.75M |
| 5 |
Exxon Mobil
XOM
|
$3.19M |
Top Sells
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
$3.42M |
| 2 |
Apple
AAPL
|
$3.42M |
| 3 |
B
Barrick Mining Corporation
B
|
$2.86M |
| 4 |
Wheaton Precious Metals
WPM
|
$2.33M |
| 5 |
Teck Resources
TECK
|
$2.04M |
Sector Composition
| 1 | Materials | 14.94% |
| 2 | Technology | 14.58% |
| 3 | Energy | 9.05% |
| 4 | Healthcare | 8.52% |
| 5 | Consumer Discretionary | 7.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Becton Dickinson
BDX
$55.3B
| $740K | 0.11% |
3,000
| – | – |
|
102
Regeneron Pharmaceuticals
REGN
$61.5B
| $709K | 0.1% |
1,200
| – | – |
|
103
Carnival Corp
CCL
$43.2B
| $692K | 0.1% |
80,000
| – | – |
|
104
Edwards Lifesciences
EW
$47.8B
| $685K | 0.1% |
7,200
-3,278
| -31% | -$312K |
|
105
Boston Scientific
BSX
$156B
| $634K | 0.09% |
+17,000
| New | +$634K |
|
106
Topgolf Callaway Brands
MODG
$1.76B
| $612K | 0.09% |
30,000
| – | – |
|
107
DexCom
DXCM
$29.5B
| $596K | 0.09% |
8,000
+6,800
| +567% | +$507K |
|
108
PVH
PVH
$4.05B
| $569K | 0.08% |
+10,000
| New | +$569K |
|
109
Illumina
ILMN
$15.8B
| $553K | 0.08% |
3,000
-280
| -9% | -$51.6K |
|
110
IQVIA
IQV
$32.4B
| $499K | 0.07% |
+2,300
| New | +$499K |
|
111
Agilent Technologies
A
$35.7B
| $499K | 0.07% |
+4,200
| New | +$499K |
|
112
Moderna
MRNA
$9.37B
| $453K | 0.07% |
3,171
| – | – |
|
113
Baxter International
BAX
$12.7B
| $450K | 0.06% |
+7,000
| New | +$450K |
|
114
Compañía de Minas Buenaventura
BVN
$4.86B
| $389K | 0.06% |
58,942
+36,942
| +168% | +$244K |
|
115
Idexx Laboratories
IDXX
$51.8B
| $386K | 0.06% |
+1,100
| New | +$386K |
|
116
Vertex Pharmaceuticals
VRTX
$100B
| $338K | 0.05% |
1,200
-1,300
| -52% | -$366K |
|
117
Arvinas
ARVN
$568M
| $337K | 0.05% |
8,000
+3,500
| +78% | +$147K |
|
118
Bunge Global
BG
$16.8B
| $307K | 0.04% |
3,390
| – | – |
|
119
Biogen
BIIB
$19.4B
| $286K | 0.04% |
+1,400
| New | +$286K |
|
120
C4 Therapeutics
CCCC
$185M
| $264K | 0.04% |
+35,000
| New | +$264K |
|
|
FTCH
121
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $215K | 0.03% |
30,000
| – | – |
|
|
SA
122
Seabridge Gold
SA
$1.78B
| $210K | 0.03% |
17,000
| – | – |
|
123
Incyte
INCY
$16.5B
| $190K | 0.03% |
2,500
-3,500
| -58% | -$266K |
|
124
Organon & Co
OGN
$2.45B
| $33.3K | ﹤0.01% |
986
| – | – |
|
125
Kinross Gold
KGC
$25.5B
| $17.8K | ﹤0.01% |
5,006
| – | – |
|